Rank | Gene Set | Z-score |
---|---|---|
1 | axoneme assembly (GO:0035082) | 7.73557115 |
2 | neutrophil activation involved in immune response (GO:0002283) | 7.06071203 |
3 | left/right pattern formation (GO:0060972) | 7.00240665 |
4 | regulation of cilium movement (GO:0003352) | 6.22684498 |
5 | modulation by symbiont of host immune response (GO:0052553) | 5.90541515 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.90541515 |
7 | modulation by symbiont of host defense response (GO:0052031) | 5.90541515 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.90541515 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.90541515 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.90541515 |
11 | response to xenobiotic stimulus (GO:0009410) | 5.79515169 |
12 | left/right axis specification (GO:0070986) | 5.53515144 |
13 | tolerance induction (GO:0002507) | 5.52578649 |
14 | respiratory burst (GO:0045730) | 5.42264530 |
15 | vitamin transmembrane transport (GO:0035461) | 5.34667025 |
16 | ventricular system development (GO:0021591) | 4.95294320 |
17 | diterpenoid biosynthetic process (GO:0016102) | 4.94444570 |
18 | response to peptidoglycan (GO:0032494) | 4.87666825 |
19 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.65777535 |
20 | microtubule bundle formation (GO:0001578) | 4.62008612 |
21 | positive regulation of tolerance induction (GO:0002645) | 4.60681406 |
22 | neutrophil activation (GO:0042119) | 4.58107725 |
23 | negative regulation of humoral immune response (GO:0002921) | 4.51497653 |
24 | granulocyte activation (GO:0036230) | 4.47580796 |
25 | macrophage activation involved in immune response (GO:0002281) | 4.45167831 |
26 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 4.36497791 |
27 | negative regulation of B cell mediated immunity (GO:0002713) | 4.36497791 |
28 | regulation of germinal center formation (GO:0002634) | 4.34677387 |
29 | cilium organization (GO:0044782) | 4.25298197 |
30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.20287237 |
31 | response to host immune response (GO:0052572) | 4.19253922 |
32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.19253922 |
33 | one-carbon compound transport (GO:0019755) | 4.14267117 |
34 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.13797883 |
35 | cilium assembly (GO:0042384) | 4.10610631 |
36 | leukocyte aggregation (GO:0070486) | 4.10485014 |
37 | intraciliary transport (GO:0042073) | 4.07408050 |
38 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.06555037 |
39 | regulation of tolerance induction (GO:0002643) | 4.01538530 |
40 | immunoglobulin mediated immune response (GO:0016064) | 3.97194674 |
41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.91125271 |
42 | ethanol oxidation (GO:0006069) | 3.90305666 |
43 | regulation of interleukin-5 production (GO:0032674) | 3.87388199 |
44 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.86237725 |
45 | lung epithelium development (GO:0060428) | 3.85209627 |
46 | cellular extravasation (GO:0045123) | 3.84478336 |
47 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.84381941 |
48 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.83277235 |
49 | glomerular epithelial cell development (GO:0072310) | 3.80038695 |
50 | myeloid cell activation involved in immune response (GO:0002275) | 3.75515554 |
51 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.75161316 |
52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.74653916 |
53 | response to host (GO:0075136) | 3.74653916 |
54 | response to host defenses (GO:0052200) | 3.74653916 |
55 | superoxide anion generation (GO:0042554) | 3.69498413 |
56 | regulation of microtubule-based movement (GO:0060632) | 3.67943298 |
57 | reactive oxygen species biosynthetic process (GO:1903409) | 3.67739082 |
58 | positive regulation of mast cell activation (GO:0033005) | 3.60847303 |
59 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.59742634 |
60 | microglial cell activation (GO:0001774) | 3.57692759 |
61 | establishment of apical/basal cell polarity (GO:0035089) | 3.56630471 |
62 | regulation of mast cell degranulation (GO:0043304) | 3.54470195 |
63 | protein localization to cilium (GO:0061512) | 3.53991804 |
64 | * primary alcohol catabolic process (GO:0034310) | 3.51835610 |
65 | regulation of interleukin-13 production (GO:0032656) | 3.43360074 |
66 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.41253181 |
67 | positive regulation of mast cell degranulation (GO:0043306) | 3.41253181 |
68 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.41192686 |
69 | phagosome maturation (GO:0090382) | 3.39740965 |
70 | positive regulation of antigen processing and presentation (GO:0002579) | 3.39520855 |
71 | retinoic acid metabolic process (GO:0042573) | 3.39267571 |
72 | centriole assembly (GO:0098534) | 3.39255254 |
73 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.35179159 |
74 | positive regulation of interferon-alpha production (GO:0032727) | 3.32143711 |
75 | detection of other organism (GO:0098543) | 3.31617432 |
76 | sperm capacitation (GO:0048240) | 3.30063234 |
77 | regulation of mast cell activation (GO:0033003) | 3.29205980 |
78 | neutrophil mediated immunity (GO:0002446) | 3.27219853 |
79 | leukocyte mediated cytotoxicity (GO:0001909) | 3.26499570 |
80 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.24942595 |
81 | iron ion import (GO:0097286) | 3.20939118 |
82 | response to muramyl dipeptide (GO:0032495) | 3.20430136 |
83 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.18040498 |
84 | regulation of leukocyte degranulation (GO:0043300) | 3.16432484 |
85 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.15437978 |
86 | positive regulation of leukocyte degranulation (GO:0043302) | 3.15243079 |
87 | * ethanol metabolic process (GO:0006067) | 3.15034091 |
88 | cellular component assembly involved in morphogenesis (GO:0010927) | 3.14480151 |
89 | detection of molecule of bacterial origin (GO:0032490) | 3.14253958 |
90 | terpenoid biosynthetic process (GO:0016114) | 3.13290167 |
91 | regulation of interferon-alpha production (GO:0032647) | 3.13168844 |
92 | amyloid precursor protein catabolic process (GO:0042987) | 3.13061212 |
93 | cellular response to zinc ion (GO:0071294) | 3.12716728 |
94 | cell projection assembly (GO:0030031) | 3.11942604 |
95 | macrophage activation (GO:0042116) | 3.09483721 |
96 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.08827172 |
97 | hypotonic response (GO:0006971) | 3.06591659 |
98 | T-helper 1 type immune response (GO:0042088) | 3.06126958 |
99 | response to fungus (GO:0009620) | 3.05479510 |
100 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.04500106 |
101 | regulation of antigen processing and presentation (GO:0002577) | 3.04159516 |
102 | neutrophil chemotaxis (GO:0030593) | 3.02925107 |
103 | low-density lipoprotein particle clearance (GO:0034383) | 3.02789743 |
104 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.01773358 |
105 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.01537416 |
106 | microtubule-based movement (GO:0007018) | 2.99880043 |
107 | apoptotic cell clearance (GO:0043277) | 2.98551628 |
108 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.97777944 |
109 | O-glycan processing (GO:0016266) | 2.97639193 |
110 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.96482966 |
111 | neutrophil migration (GO:1990266) | 2.95339530 |
112 | cilium morphogenesis (GO:0060271) | 2.95328614 |
113 | detection of external biotic stimulus (GO:0098581) | 2.93535268 |
114 | leukocyte degranulation (GO:0043299) | 2.92246514 |
115 | leukotriene metabolic process (GO:0006691) | 2.91964112 |
116 | establishment of monopolar cell polarity (GO:0061162) | 2.91668070 |
117 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.91668070 |
118 | negative regulation of mast cell activation (GO:0033004) | 2.90511002 |
119 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.90428299 |
120 | progesterone metabolic process (GO:0042448) | 2.89769172 |
121 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.89725584 |
122 | detection of bacterium (GO:0016045) | 2.89623877 |
123 | sequestering of metal ion (GO:0051238) | 2.89576133 |
124 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.88369670 |
125 | retinol metabolic process (GO:0042572) | 2.88116590 |
126 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.86852864 |
127 | positive regulation of macrophage cytokine production (GO:0060907) | 2.86581230 |
128 | regulation of mononuclear cell migration (GO:0071675) | 2.82933061 |
129 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.82052724 |
130 | natural killer cell mediated immunity (GO:0002228) | 2.82052724 |
131 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.81986206 |
132 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.80118086 |
133 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.79661683 |
134 | pinocytosis (GO:0006907) | 2.76428979 |
135 | regulation of monocyte chemotaxis (GO:0090025) | 2.75031770 |
136 | cytoplasmic microtubule organization (GO:0031122) | 2.72810661 |
137 | regulation of cholesterol storage (GO:0010885) | 2.72686009 |
138 | myeloid leukocyte activation (GO:0002274) | 2.71967618 |
139 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.71608730 |
140 | granulocyte chemotaxis (GO:0071621) | 2.71105591 |
141 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.70498586 |
142 | exogenous drug catabolic process (GO:0042738) | 2.70387068 |
143 | leukocyte cell-cell adhesion (GO:0007159) | 2.65691979 |
144 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.63713027 |
145 | granulocyte migration (GO:0097530) | 2.63426179 |
146 | regulation of autophagic vacuole assembly (GO:2000785) | 2.63091682 |
147 | glutathione derivative biosynthetic process (GO:1901687) | 2.63042633 |
148 | glutathione derivative metabolic process (GO:1901685) | 2.63042633 |
149 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.61971676 |
150 | response to lipoprotein particle (GO:0055094) | 2.60616884 |
151 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.60278313 |
152 | negative regulation of interleukin-17 production (GO:0032700) | 2.59419143 |
153 | negative regulation of interleukin-6 production (GO:0032715) | 2.59208113 |
154 | regulation of podosome assembly (GO:0071801) | 2.58611716 |
155 | hydrogen peroxide catabolic process (GO:0042744) | 2.58404688 |
156 | B cell mediated immunity (GO:0019724) | 2.58223864 |
157 | lipoxygenase pathway (GO:0019372) | 2.58043467 |
158 | negative regulation of adaptive immune response (GO:0002820) | 2.57748861 |
159 | positive regulation of extracellular matrix organization (GO:1903055) | 2.57439055 |
160 | eosinophil chemotaxis (GO:0048245) | 2.56704177 |
161 | detection of biotic stimulus (GO:0009595) | 2.53462729 |
162 | negative regulation of interleukin-12 production (GO:0032695) | 2.51998947 |
163 | regulation of response to osmotic stress (GO:0047484) | 2.51570630 |
164 | lateral ventricle development (GO:0021670) | 2.41156759 |
165 | negative regulation of inclusion body assembly (GO:0090084) | 2.38229382 |
166 | barbed-end actin filament capping (GO:0051016) | 2.36153211 |
167 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.35707860 |
168 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.34496039 |
169 | hydrogen peroxide metabolic process (GO:0042743) | 2.33668881 |
170 | carnitine metabolic process (GO:0009437) | 2.31229106 |
171 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.25731553 |
172 | regulation of vacuole organization (GO:0044088) | 2.25479248 |
173 | multicellular organismal water homeostasis (GO:0050891) | 2.24209939 |
174 | cellular response to exogenous dsRNA (GO:0071360) | 2.22694246 |
175 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.21923156 |
176 | carnitine transmembrane transport (GO:1902603) | 2.20881467 |
177 | regulation of metalloenzyme activity (GO:0048552) | 2.20347553 |
178 | glutathione biosynthetic process (GO:0006750) | 2.19300700 |
179 | oligosaccharide biosynthetic process (GO:0009312) | 2.19190462 |
180 | regulation of cilium assembly (GO:1902017) | 2.19148688 |
181 | * primary alcohol metabolic process (GO:0034308) | 2.17510402 |
182 | renal absorption (GO:0070293) | 2.17432405 |
183 | axonemal dynein complex assembly (GO:0070286) | 17.3077531 |
184 | cilium or flagellum-dependent cell motility (GO:0001539) | 14.7551561 |
185 | cilium movement (GO:0003341) | 12.0453566 |
186 | motile cilium assembly (GO:0044458) | 11.8925580 |
187 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 11.0986012 |
188 | epithelial cilium movement (GO:0003351) | 10.2039068 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.49919723 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.73029490 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.87014878 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.35345918 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.06194777 |
6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.90253497 |
7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.83683207 |
8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.53728387 |
9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.15126295 |
10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.14203713 |
11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.04794629 |
12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.67358470 |
13 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.64739570 |
14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.54723144 |
15 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.52119465 |
16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.44169255 |
17 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.34648473 |
18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.33570474 |
19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.32117226 |
20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.24953961 |
21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.05723514 |
22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.93515984 |
23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.89073207 |
24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.89054189 |
25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.88836422 |
26 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.86042957 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.84614986 |
28 | SPI1_23127762_ChIP-Seq_K562_Human | 1.80490509 |
29 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.78735154 |
30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77713867 |
31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.77371508 |
32 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.77292279 |
33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.76791176 |
34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72623613 |
35 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.70892966 |
36 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.69104933 |
37 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68886040 |
38 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.66759701 |
39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65808053 |
40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.60542680 |
41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60281654 |
42 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.59813054 |
43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.59699811 |
44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59357903 |
45 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.59306048 |
46 | P68_20966046_ChIP-Seq_HELA_Human | 1.57309722 |
47 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.55763647 |
48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55322465 |
49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.55292442 |
50 | MYB_26560356_Chip-Seq_TH2_Human | 1.53027168 |
51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.48996494 |
52 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.48380635 |
53 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.48051110 |
54 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47870480 |
55 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.46743430 |
56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45899929 |
57 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45260060 |
58 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.42519028 |
59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41510727 |
60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.41474071 |
61 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40545640 |
62 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.37545540 |
63 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.34031052 |
64 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33483693 |
65 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32842399 |
66 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.32289838 |
67 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.31299944 |
68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.30829692 |
69 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.30704970 |
70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30331609 |
71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29877313 |
72 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29271089 |
73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29149766 |
74 | MAF_26560356_Chip-Seq_TH1_Human | 1.28467876 |
75 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.27792434 |
76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.27237194 |
77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.27237194 |
78 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26581234 |
79 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25591818 |
80 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.24296716 |
81 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.24070896 |
82 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21574367 |
83 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21270330 |
84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.19888619 |
85 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19630565 |
86 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.19406129 |
87 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19297584 |
88 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19205447 |
89 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19147469 |
90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18951626 |
91 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18198627 |
92 | P300_27268052_Chip-Seq_Bcells_Human | 1.17600520 |
93 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16704744 |
94 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15638884 |
95 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.14866088 |
96 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.12917738 |
97 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11630629 |
98 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11204016 |
99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11112279 |
100 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11044898 |
101 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.10642340 |
102 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.09749463 |
103 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09405639 |
104 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07504364 |
105 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07402797 |
106 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05845792 |
107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05502294 |
108 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.05465167 |
109 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04363414 |
110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02293365 |
111 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00599771 |
112 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00528342 |
113 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00170234 |
114 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00031927 |
115 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99822817 |
116 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99675882 |
117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99649147 |
118 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99024142 |
119 | MYB_26560356_Chip-Seq_TH1_Human | 0.98593795 |
120 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.98557008 |
121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98181217 |
122 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98121925 |
123 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95492667 |
124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95436688 |
125 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94799657 |
126 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92320978 |
127 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91632551 |
128 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90553231 |
129 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89821450 |
130 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89227204 |
131 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88078407 |
132 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.85873245 |
133 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85857482 |
134 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85756079 |
135 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.85408087 |
136 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85241141 |
137 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85226550 |
138 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83602422 |
139 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82494389 |
140 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.81271735 |
141 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80858267 |
142 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.79726240 |
143 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.78440232 |
144 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78228783 |
145 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.77062742 |
146 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.74053444 |
147 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73386094 |
148 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.72820642 |
149 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72158620 |
150 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.72051449 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008875_abnormal_xenobiotic_pharmacok | 5.60088059 |
2 | MP0002132_abnormal_respiratory_system | 4.74715010 |
3 | MP0005058_abnormal_lysosome_morphology | 4.47355001 |
4 | MP0002653_abnormal_ependyma_morphology | 4.23978860 |
5 | MP0003436_decreased_susceptibility_to | 3.86101660 |
6 | MP0001835_abnormal_antigen_presentation | 3.79546125 |
7 | MP0003303_peritoneal_inflammation | 3.77424245 |
8 | MP0002419_abnormal_innate_immunity | 3.34944611 |
9 | MP0009785_altered_susceptibility_to | 3.24072010 |
10 | MP0002148_abnormal_hypersensitivity_rea | 2.99272060 |
11 | MP0005000_abnormal_immune_tolerance | 2.84982193 |
12 | MP0006082_CNS_inflammation | 2.78399324 |
13 | MP0005025_abnormal_response_to | 2.74647676 |
14 | MP0005387_immune_system_phenotype | 2.62654871 |
15 | MP0001790_abnormal_immune_system | 2.62654871 |
16 | MP0003724_increased_susceptibility_to | 2.62113884 |
17 | MP0003183_abnormal_peptide_metabolism | 2.55076972 |
18 | MP0002452_abnormal_antigen_presenting | 2.41429365 |
19 | MP0001533_abnormal_skeleton_physiology | 2.34227481 |
20 | MP0009840_abnormal_foam_cell | 2.28597640 |
21 | MP0004043_abnormal_pH_regulation | 2.27622224 |
22 | MP0003172_abnormal_lysosome_physiology | 2.26946043 |
23 | MP0003191_abnormal_cellular_cholesterol | 2.17361660 |
24 | MP0002723_abnormal_immune_serum | 2.15385035 |
25 | MP0004510_myositis | 2.15333845 |
26 | MP0000685_abnormal_immune_system | 2.15284445 |
27 | MP0000920_abnormal_myelination | 2.11689233 |
28 | MP0001800_abnormal_humoral_immune | 2.11385200 |
29 | MP0003075_altered_response_to | 2.11261644 |
30 | MP0005623_abnormal_meninges_morphology | 2.00399686 |
31 | MP0001819_abnormal_immune_cell | 1.99107752 |
32 | MP0002420_abnormal_adaptive_immunity | 1.98518180 |
33 | MP0005464_abnormal_platelet_physiology | 1.98286110 |
34 | MP0003690_abnormal_glial_cell | 1.95095759 |
35 | MP0000343_altered_response_to | 1.91084480 |
36 | MP0000604_amyloidosis | 1.89469725 |
37 | MP0002405_respiratory_system_inflammati | 1.89216478 |
38 | MP0004133_heterotaxia | 1.84454495 |
39 | MP0009780_abnormal_chondrocyte_physiolo | 1.83423600 |
40 | MP0001845_abnormal_inflammatory_respons | 1.73209078 |
41 | MP0009278_abnormal_bone_marrow | 1.72958318 |
42 | MP0009764_decreased_sensitivity_to | 1.70308355 |
43 | MP0004019_abnormal_vitamin_homeostasis | 1.68080631 |
44 | MP0004947_skin_inflammation | 1.65974273 |
45 | MP0008260_abnormal_autophagy | 1.65645411 |
46 | MP0005671_abnormal_response_to | 1.65060882 |
47 | MP0003806_abnormal_nucleotide_metabolis | 1.64547850 |
48 | MP0001958_emphysema | 1.62883936 |
49 | MP0003878_abnormal_ear_physiology | 1.62394706 |
50 | MP0005377_hearing/vestibular/ear_phenot | 1.62394706 |
51 | MP0001984_abnormal_olfaction | 1.61623716 |
52 | MP0003448_altered_tumor_morphology | 1.60513009 |
53 | MP0001851_eye_inflammation | 1.58415625 |
54 | MP0002168_other_aberrant_phenotype | 1.55783711 |
55 | MP0005167_abnormal_blood-brain_barrier | 1.54269349 |
56 | MP0004782_abnormal_surfactant_physiolog | 1.54080146 |
57 | MP0003300_gastrointestinal_ulcer | 1.53379934 |
58 | MP0008469_abnormal_protein_level | 1.46900632 |
59 | MP0001765_abnormal_ion_homeostasis | 1.45501824 |
60 | MP0005310_abnormal_salivary_gland | 1.45022016 |
61 | MP0002933_joint_inflammation | 1.43105130 |
62 | MP0005165_increased_susceptibility_to | 1.40985600 |
63 | MP0002998_abnormal_bone_remodeling | 1.36932394 |
64 | MP0008789_abnormal_olfactory_epithelium | 1.34079639 |
65 | MP0000383_abnormal_hair_follicle | 1.33843540 |
66 | MP0000716_abnormal_immune_system | 1.33713365 |
67 | MP0005166_decreased_susceptibility_to | 1.31337951 |
68 | MP0002139_abnormal_hepatobiliary_system | 1.24443220 |
69 | MP0001853_heart_inflammation | 1.23217533 |
70 | MP0005164_abnormal_response_to | 1.23034933 |
71 | MP0009333_abnormal_splenocyte_physiolog | 1.20059601 |
72 | MP0010155_abnormal_intestine_physiology | 1.19252661 |
73 | MP0005365_abnormal_bile_salt | 1.18373012 |
74 | MP0010678_abnormal_skin_adnexa | 1.17927915 |
75 | MP0008438_abnormal_cutaneous_collagen | 1.14703511 |
76 | MP0003950_abnormal_plasma_membrane | 1.14306584 |
77 | MP0000858_altered_metastatic_potential | 1.12878696 |
78 | MP0000681_abnormal_thyroid_gland | 1.10850010 |
79 | MP0003656_abnormal_erythrocyte_physiolo | 1.09217485 |
80 | MP0005390_skeleton_phenotype | 1.08534529 |
81 | MP0003566_abnormal_cell_adhesion | 1.08432230 |
82 | MP0001849_ear_inflammation | 1.07899815 |
83 | MP0002277_abnormal_respiratory_mucosa | 1.06188687 |
84 | MP0000678_abnormal_parathyroid_gland | 1.05251895 |
85 | MP0009643_abnormal_urine_homeostasis | 1.03737588 |
86 | MP0002282_abnormal_trachea_morphology | 1.01919931 |
87 | MP0003634_abnormal_glial_cell | 1.01814350 |
88 | MP0000689_abnormal_spleen_morphology | 1.01753847 |
89 | MP0002429_abnormal_blood_cell | 1.01675704 |
90 | MP0004883_abnormal_blood_vessel | 1.00961537 |
91 | MP0003186_abnormal_redox_activity | 1.00718497 |
92 | MP0002398_abnormal_bone_marrow | 0.99906088 |
93 | MP0000465_gastrointestinal_hemorrhage | 0.98464926 |
94 | MP0005174_abnormal_tail_pigmentation | 0.98249513 |
95 | MP0008004_abnormal_stomach_pH | 0.96146500 |
96 | MP0010234_abnormal_vibrissa_follicle | 0.95486217 |
97 | MP0003329_amyloid_beta_deposits | 0.94350667 |
98 | MP0003866_abnormal_defecation | 0.93956638 |
99 | MP0003453_abnormal_keratinocyte_physiol | 0.91276973 |
100 | MP0005636_abnormal_mineral_homeostasis | 0.91085765 |
101 | MP0001542_abnormal_bone_strength | 0.89181539 |
102 | MP0003195_calcinosis | 0.88672152 |
103 | MP0001545_abnormal_hematopoietic_system | 0.88076541 |
104 | MP0005397_hematopoietic_system_phenotyp | 0.88076541 |
105 | MP0000249_abnormal_blood_vessel | 0.87773985 |
106 | MP0005083_abnormal_biliary_tract | 0.86419234 |
107 | MP0002722_abnormal_immune_system | 0.82996457 |
108 | MP0002138_abnormal_hepatobiliary_system | 0.81896321 |
109 | MP0001873_stomach_inflammation | 0.81808292 |
110 | MP0005085_abnormal_gallbladder_physiolo | 0.81742707 |
111 | MP0002295_abnormal_pulmonary_circulatio | 0.80900443 |
112 | MP0009763_increased_sensitivity_to | 0.79409352 |
113 | MP0003091_abnormal_cell_migration | 0.78973073 |
114 | MP0005248_abnormal_Harderian_gland | 0.78751456 |
115 | MP0002006_tumorigenesis | 0.78507360 |
116 | MP0009765_abnormal_xenobiotic_induced | 0.78098090 |
117 | MP0005171_absent_coat_pigmentation | 0.77395390 |
118 | MP0002133_abnormal_respiratory_system | 0.76767157 |
119 | MP0005388_respiratory_system_phenotype | 0.76767157 |
120 | MP0005257_abnormal_intraocular_pressure | 0.75459284 |
121 | MP0005319_abnormal_enzyme/_coenzyme | 0.74326074 |
122 | MP0005395_other_phenotype | 0.73536044 |
123 | MP0003045_fibrosis | 0.73523874 |
124 | MP0005023_abnormal_wound_healing | 0.73256211 |
125 | MP0003795_abnormal_bone_structure | 0.71986279 |
126 | MP0002166_altered_tumor_susceptibility | 0.70120319 |
127 | MP0004742_abnormal_vestibular_system | 0.67871565 |
128 | MP0000015_abnormal_ear_pigmentation | 0.67843716 |
129 | MP0001663_abnormal_digestive_system | 0.67475658 |
130 | MP0002136_abnormal_kidney_physiology | 0.66751808 |
131 | MP0003828_pulmonary_edema | 0.65923093 |
132 | MP0005076_abnormal_cell_differentiation | 0.65089664 |
133 | MP0002090_abnormal_vision | 0.65081228 |
134 | MP0002160_abnormal_reproductive_system | 0.64044103 |
135 | MP0003279_aneurysm | 0.62976740 |
136 | MP0005410_abnormal_fertilization | 0.61520310 |
137 | MP0004185_abnormal_adipocyte_glucose | 0.60844825 |
138 | MP0000569_abnormal_digit_pigmentation | 0.60567919 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Rhinitis (HP:0012384) | 9.33860486 |
2 | Recurrent abscess formation (HP:0002722) | 7.43371244 |
3 | Eczematoid dermatitis (HP:0000976) | 7.20773411 |
4 | Chronic bronchitis (HP:0004469) | 7.19225006 |
5 | Bronchiectasis (HP:0002110) | 6.89432738 |
6 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.59538544 |
7 | Recurrent bacterial skin infections (HP:0005406) | 6.41821303 |
8 | Abnormality of macrophages (HP:0004311) | 5.98662916 |
9 | Vacuolated lymphocytes (HP:0001922) | 5.52704824 |
10 | Increased cerebral lipofuscin (HP:0011813) | 4.86210300 |
11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.49804339 |
12 | Axonal loss (HP:0003447) | 4.44500814 |
13 | Recurrent sinusitis (HP:0011108) | 4.37106675 |
14 | Systemic lupus erythematosus (HP:0002725) | 4.33511147 |
15 | Obstructive lung disease (HP:0006536) | 4.29868007 |
16 | Chronic obstructive pulmonary disease (HP:0006510) | 4.29868007 |
17 | Interstitial pulmonary disease (HP:0006530) | 4.20382251 |
18 | Bronchitis (HP:0012387) | 4.13450619 |
19 | Dysostosis multiplex (HP:0000943) | 3.98153417 |
20 | Mediastinal lymphadenopathy (HP:0100721) | 3.97921233 |
21 | Chronic sinusitis (HP:0011109) | 3.97622423 |
22 | Recurrent skin infections (HP:0001581) | 3.96786147 |
23 | Infertility (HP:0000789) | 3.95181322 |
24 | Disinhibition (HP:0000734) | 3.89812068 |
25 | Gingivitis (HP:0000230) | 3.83119122 |
26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.75262124 |
27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.75262124 |
28 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.75262124 |
29 | Male infertility (HP:0003251) | 3.69128814 |
30 | Recurrent otitis media (HP:0000403) | 3.67542665 |
31 | Cellulitis (HP:0100658) | 3.65117199 |
32 | Stomatitis (HP:0010280) | 3.54611994 |
33 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.49690921 |
34 | Myositis (HP:0100614) | 3.40215043 |
35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.22543621 |
36 | Hepatosplenomegaly (HP:0001433) | 3.18664348 |
37 | Orchitis (HP:0100796) | 3.15735167 |
38 | Loss of speech (HP:0002371) | 3.15123821 |
39 | Recurrent fungal infections (HP:0002841) | 3.13735592 |
40 | Occipital encephalocele (HP:0002085) | 3.07369033 |
41 | Pancreatic fibrosis (HP:0100732) | 3.00197658 |
42 | Atelectasis (HP:0100750) | 2.93927538 |
43 | True hermaphroditism (HP:0010459) | 2.92219450 |
44 | Osteomyelitis (HP:0002754) | 2.91192391 |
45 | Urticaria (HP:0001025) | 2.89588803 |
46 | Neurofibrillary tangles (HP:0002185) | 2.88340798 |
47 | Hyperactive renin-angiotensin system (HP:0000841) | 2.81833475 |
48 | Recurrent pneumonia (HP:0006532) | 2.78986709 |
49 | Optic neuritis (HP:0100653) | 2.78795958 |
50 | Retrobulbar optic neuritis (HP:0100654) | 2.78795958 |
51 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.73447167 |
52 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.71199519 |
53 | Mucopolysacchariduria (HP:0008155) | 2.71199519 |
54 | Vasculitis (HP:0002633) | 2.68785660 |
55 | Autoimmune thrombocytopenia (HP:0001973) | 2.67847283 |
56 | Meningitis (HP:0001287) | 2.67080003 |
57 | Spontaneous hematomas (HP:0007420) | 2.64064003 |
58 | Glomerulonephritis (HP:0000099) | 2.63976844 |
59 | Cystic liver disease (HP:0006706) | 2.61435949 |
60 | Osteolytic defects of the hand bones (HP:0009699) | 2.53767810 |
61 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.53767810 |
62 | Molar tooth sign on MRI (HP:0002419) | 2.52269850 |
63 | Abnormality of midbrain morphology (HP:0002418) | 2.52269850 |
64 | Chronic otitis media (HP:0000389) | 2.51145789 |
65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.48960680 |
66 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.48960680 |
67 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.48960680 |
68 | Peripheral demyelination (HP:0011096) | 2.48533901 |
69 | Pustule (HP:0200039) | 2.48243131 |
70 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.46674474 |
71 | Pancreatic cysts (HP:0001737) | 2.36644236 |
72 | J-shaped sella turcica (HP:0002680) | 2.35438063 |
73 | Recurrent viral infections (HP:0004429) | 2.29046385 |
74 | Supranuclear gaze palsy (HP:0000605) | 2.28267791 |
75 | Abnormality of the nasal mucosa (HP:0000433) | 2.23520238 |
76 | Recurrent lower respiratory tract infections (HP:0002783) | 2.21595359 |
77 | Periodontitis (HP:0000704) | 2.21188171 |
78 | Nephritis (HP:0000123) | 2.20508679 |
79 | Nephronophthisis (HP:0000090) | 2.20469504 |
80 | Hematochezia (HP:0002573) | 2.17919424 |
81 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.16364194 |
82 | Amyloidosis (HP:0011034) | 2.16216886 |
83 | Basal ganglia calcification (HP:0002135) | 2.08660234 |
84 | Absent frontal sinuses (HP:0002688) | 2.06538630 |
85 | Peripheral hypomyelination (HP:0007182) | 2.05145536 |
86 | Sepsis (HP:0100806) | 2.05073772 |
87 | Purpura (HP:0000979) | 2.04375397 |
88 | Nasal polyposis (HP:0100582) | 2.04360398 |
89 | Conjunctival telangiectasia (HP:0000524) | 2.03249690 |
90 | Recurrent bronchitis (HP:0002837) | 2.03230728 |
91 | Thick nail (HP:0001805) | 2.03052029 |
92 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 11.5988994 |
93 | Abnormal respiratory motile cilium morphology (HP:0005938) | 10.6306211 |
94 | Abnormal respiratory epithelium morphology (HP:0012253) | 10.6306211 |
95 | Absent/shortened dynein arms (HP:0200106) | 10.3635307 |
96 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 10.3635307 |
97 | Abnormal respiratory motile cilium physiology (HP:0012261) | 10.1872127 |
98 | Abnormal ciliary motility (HP:0012262) | 10.0199737 |
99 | Pulmonary infiltrates (HP:0002113) | 1.99673088 |
100 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99547689 |
101 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99547689 |
102 | Restrictive lung disease (HP:0002091) | 1.99100190 |
103 | Chronic hepatic failure (HP:0100626) | 1.96545809 |
104 | Inflammation of the large intestine (HP:0002037) | 1.96459963 |
105 | Postaxial foot polydactyly (HP:0001830) | 1.95100030 |
106 | Abnormality of complement system (HP:0005339) | 1.94378707 |
107 | Bone pain (HP:0002653) | 1.94184669 |
108 | Cerebral inclusion bodies (HP:0100314) | 1.93870576 |
109 | Myocardial infarction (HP:0001658) | 1.91764032 |
110 | Hemoptysis (HP:0002105) | 1.89705840 |
111 | Petechiae (HP:0000967) | 1.87064588 |
112 | Progressive neurologic deterioration (HP:0002344) | 1.87052880 |
113 | Joint hemorrhage (HP:0005261) | 1.86999648 |
114 | Bell-shaped thorax (HP:0001591) | 1.86527250 |
115 | Decreased circulating renin level (HP:0003351) | 1.86135337 |
116 | Congenital hepatic fibrosis (HP:0002612) | 1.85483223 |
117 | Pathologic fracture (HP:0002756) | 1.84751989 |
118 | Parakeratosis (HP:0001036) | 1.83060580 |
119 | Colitis (HP:0002583) | 1.82007295 |
120 | Hemorrhage of the eye (HP:0011885) | 1.79834532 |
121 | Leukocytosis (HP:0001974) | 1.79183339 |
122 | Nephropathy (HP:0000112) | 1.79073601 |
123 | Gastrointestinal stroma tumor (HP:0100723) | 1.78740037 |
124 | Thoracic kyphosis (HP:0002942) | 1.78604968 |
125 | IgM deficiency (HP:0002850) | 1.78495033 |
126 | Prostate neoplasm (HP:0100787) | 1.76969887 |
127 | Abnormality of the lumbar spine (HP:0100712) | 1.75588879 |
128 | Poor head control (HP:0002421) | 1.74661548 |
129 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.74279379 |
130 | Vertebral compression fractures (HP:0002953) | 1.73427280 |
131 | Akinesia (HP:0002304) | 1.73328931 |
132 | Progressive visual loss (HP:0000529) | 1.72748397 |
133 | Inappropriate behavior (HP:0000719) | 1.72503441 |
134 | Tubulointerstitial nephritis (HP:0001970) | 1.71929516 |
135 | Abnormality of the renal medulla (HP:0100957) | 1.71599013 |
136 | Skin ulcer (HP:0200042) | 1.70564436 |
137 | Gastrointestinal inflammation (HP:0004386) | 1.70153297 |
138 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.68986169 |
139 | Renal salt wasting (HP:0000127) | 1.66875279 |
140 | Anencephaly (HP:0002323) | 1.66764035 |
141 | Short nail (HP:0001799) | 1.57186750 |
142 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.54643703 |
143 | Male pseudohermaphroditism (HP:0000037) | 1.54528646 |
144 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.54193238 |
145 | Glucose intolerance (HP:0000833) | 1.53443394 |
146 | Tubular atrophy (HP:0000092) | 1.52863870 |
147 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.50321643 |
148 | Oculomotor apraxia (HP:0000657) | 1.49675865 |
149 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.49405047 |
150 | Asplenia (HP:0001746) | 1.47589664 |
151 | Furrowed tongue (HP:0000221) | 1.45448699 |
152 | Abnormality of the frontal sinuses (HP:0002687) | 1.37326803 |
153 | Hyperkalemia (HP:0002153) | 1.37289032 |
154 | Abnormality of renin-angiotensin system (HP:0000847) | 1.32388521 |
155 | Hyperaldosteronism (HP:0000859) | 1.31428046 |
156 | Increased serum ferritin (HP:0003281) | 1.30639357 |
157 | Medial flaring of the eyebrow (HP:0010747) | 1.29171124 |
158 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.28317994 |
159 | Abnormality of chloride homeostasis (HP:0011422) | 1.27338276 |
160 | Hand muscle atrophy (HP:0009130) | 1.25436130 |
161 | Short femoral neck (HP:0100864) | 1.25184066 |
162 | Distal lower limb muscle weakness (HP:0009053) | 1.23001587 |
163 | Sclerocornea (HP:0000647) | 1.21715382 |
164 | Cone-rod dystrophy (HP:0000548) | 1.20272371 |
165 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.17875823 |
166 | Congenital primary aphakia (HP:0007707) | 1.17623023 |
167 | Short thorax (HP:0010306) | 1.17266558 |
168 | Hypokalemic alkalosis (HP:0001949) | 1.14171557 |
169 | Vascular calcification (HP:0004934) | 1.13055934 |
170 | Abnormal glucose tolerance (HP:0001952) | 1.12145771 |
171 | Stridor (HP:0010307) | 1.12053528 |
172 | Decreased central vision (HP:0007663) | 1.12034297 |
173 | Diaphragmatic weakness (HP:0009113) | 1.11991849 |
174 | Flat acetabular roof (HP:0003180) | 1.11893655 |
175 | Stage 5 chronic kidney disease (HP:0003774) | 1.10848707 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAPK15 | 8.68738771 |
2 | EPHA2 | 4.39177560 |
3 | BLK | 4.25338259 |
4 | RIPK4 | 3.63404222 |
5 | EPHB1 | 3.28736378 |
6 | IRAK4 | 3.16795158 |
7 | MAP4K1 | 3.15000828 |
8 | MAP3K3 | 2.84630119 |
9 | PBK | 2.78069954 |
10 | ERN1 | 2.77304960 |
11 | MST4 | 2.62883860 |
12 | MAP3K14 | 2.61769432 |
13 | TBK1 | 2.52320015 |
14 | FGR | 2.41865278 |
15 | TRIB3 | 2.04986234 |
16 | CSK | 1.97577558 |
17 | MAPKAPK3 | 1.91293181 |
18 | IRAK3 | 1.84978198 |
19 | KIT | 1.70822214 |
20 | TYK2 | 1.68612245 |
21 | TRPM7 | 1.67755905 |
22 | SMG1 | 1.64357550 |
23 | CSF1R | 1.63019761 |
24 | FES | 1.59584638 |
25 | STK10 | 1.56463653 |
26 | IKBKB | 1.47559401 |
27 | IKBKE | 1.43207331 |
28 | HCK | 1.41667786 |
29 | TGFBR2 | 1.38216500 |
30 | BTK | 1.33252784 |
31 | ZAP70 | 1.32836421 |
32 | LRRK2 | 1.29876725 |
33 | STK39 | 1.29470730 |
34 | TLK1 | 1.27404730 |
35 | CLK1 | 1.20606808 |
36 | ARAF | 1.18505395 |
37 | MARK2 | 1.16611201 |
38 | MAP3K13 | 1.15836758 |
39 | KSR2 | 1.14817583 |
40 | ABL2 | 1.13207620 |
41 | NME1 | 1.13021260 |
42 | SYK | 1.11527238 |
43 | TEC | 1.09857514 |
44 | MAP3K7 | 1.09210368 |
45 | PIM2 | 1.08813027 |
46 | LYN | 1.08544097 |
47 | RIPK1 | 1.07451813 |
48 | TAOK1 | 1.04816809 |
49 | EEF2K | 1.04355653 |
50 | JAK1 | 1.01450627 |
51 | JAK3 | 1.00854134 |
52 | MET | 0.99991085 |
53 | MAP2K3 | 0.98592612 |
54 | LCK | 0.98338983 |
55 | ITK | 0.96451388 |
56 | TESK1 | 0.95698619 |
57 | NEK9 | 0.94351677 |
58 | STK24 | 0.89995602 |
59 | PKN1 | 0.89123362 |
60 | TXK | 0.88364052 |
61 | TTN | 0.87160536 |
62 | BMX | 0.87000888 |
63 | CDC42BPA | 0.86414468 |
64 | PTK6 | 0.84713797 |
65 | EGFR | 0.82836768 |
66 | MOS | 0.78593828 |
67 | ICK | 0.78576701 |
68 | PRKD2 | 0.78220534 |
69 | MST1R | 0.77080292 |
70 | PRKCD | 0.75408148 |
71 | TAOK3 | 0.74450582 |
72 | GRK6 | 0.74392030 |
73 | STK38 | 0.73936362 |
74 | PAK4 | 0.73781133 |
75 | HIPK2 | 0.73482155 |
76 | PDPK1 | 0.69369223 |
77 | FYN | 0.68939372 |
78 | ABL1 | 0.67928008 |
79 | PRKCQ | 0.67747432 |
80 | JAK2 | 0.67726865 |
81 | NTRK1 | 0.67532017 |
82 | NME2 | 0.66551483 |
83 | MARK3 | 0.64665854 |
84 | PRKCI | 0.64665042 |
85 | ERBB3 | 0.63856108 |
86 | MATK | 0.63504614 |
87 | IRAK1 | 0.63256665 |
88 | TAOK2 | 0.62931839 |
89 | TNK2 | 0.61443503 |
90 | ACVR1B | 0.61253738 |
91 | MAP3K1 | 0.60131704 |
92 | CAMK1D | 0.59893372 |
93 | RPS6KA4 | 0.59293790 |
94 | MAP3K11 | 0.59074136 |
95 | STK4 | 0.58662637 |
96 | BMPR2 | 0.58608075 |
97 | NEK6 | 0.58279486 |
98 | ADRBK2 | 0.55981375 |
99 | PTK2B | 0.54891882 |
100 | RPS6KA2 | 0.54559892 |
101 | PRKCH | 0.53769095 |
102 | SIK1 | 0.52757766 |
103 | ADRBK1 | 0.52617095 |
104 | CAMKK2 | 0.52471217 |
105 | CAMKK1 | 0.51701340 |
106 | TESK2 | 0.51694532 |
107 | DAPK3 | 0.51612017 |
108 | MAP3K2 | 0.51003464 |
109 | MAPKAPK2 | 0.50967708 |
110 | PIK3CG | 0.50909219 |
111 | PRKG2 | 0.48976721 |
112 | BMPR1B | 0.48199020 |
113 | PDK1 | 0.47737316 |
114 | LMTK2 | 0.45934855 |
115 | MAP2K2 | 0.45611430 |
116 | CHUK | 0.44360076 |
117 | MAP3K6 | 0.44095820 |
118 | PTK2 | 0.43382145 |
119 | PRKAA2 | 0.42309264 |
120 | PDGFRB | 0.41437351 |
121 | MYLK | 0.39834358 |
122 | PIM1 | 0.39305853 |
123 | GRK7 | 0.39143072 |
124 | INSR | 0.39107811 |
125 | GSK3A | 0.38359469 |
126 | CAMK1G | 0.37853853 |
127 | PRKD1 | 0.36174309 |
128 | DYRK1B | 0.35575027 |
129 | ILK | 0.34235050 |
130 | LIMK1 | 0.33567535 |
131 | KDR | 0.33334126 |
132 | MAP2K1 | 0.33320056 |
133 | PRPF4B | 0.33272154 |
134 | EPHA3 | 0.32654610 |
135 | CAMK2G | 0.31950253 |
136 | OXSR1 | 0.31923786 |
137 | ERBB2 | 0.31807642 |
138 | RPS6KA6 | 0.30175762 |
139 | MAPK11 | 0.28998358 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.66399137 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.64006839 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.20107088 |
4 | Lysosome_Homo sapiens_hsa04142 | 3.09891796 |
5 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.05049736 |
6 | Phagosome_Homo sapiens_hsa04145 | 2.48040828 |
7 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.46902048 |
8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.45171071 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.39050333 |
10 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.28813192 |
11 | Malaria_Homo sapiens_hsa05144 | 2.25978875 |
12 | Tuberculosis_Homo sapiens_hsa05152 | 2.23646952 |
13 | Pertussis_Homo sapiens_hsa05133 | 2.20689398 |
14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.19628647 |
15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.17332891 |
16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.04230688 |
17 | Legionellosis_Homo sapiens_hsa05134 | 2.01249065 |
18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97037521 |
19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.87246825 |
20 | Salmonella infection_Homo sapiens_hsa05132 | 1.84953784 |
21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.80959846 |
22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.80535829 |
23 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.64557495 |
24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.58384300 |
25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.54098209 |
26 | Shigellosis_Homo sapiens_hsa05131 | 1.51657467 |
27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.50582938 |
28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.48632868 |
29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45435582 |
30 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44249237 |
31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38236235 |
32 | Asthma_Homo sapiens_hsa05310 | 1.38141577 |
33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34989897 |
34 | ABC transporters_Homo sapiens_hsa02010 | 1.34435411 |
35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.33165890 |
36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32048871 |
37 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26576636 |
38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25685282 |
39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.24382402 |
40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.23533865 |
41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22123830 |
42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21860116 |
43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.19984128 |
44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.18558912 |
45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16999080 |
46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.14408496 |
47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14330892 |
48 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.12872364 |
49 | Apoptosis_Homo sapiens_hsa04210 | 1.11912556 |
50 | Measles_Homo sapiens_hsa05162 | 1.09567605 |
51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.09364387 |
52 | Huntingtons disease_Homo sapiens_hsa05016 | 1.09083152 |
53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.06634639 |
54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.05210172 |
55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.05176875 |
56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.05098488 |
57 | Amoebiasis_Homo sapiens_hsa05146 | 1.02368217 |
58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01911165 |
59 | Mineral absorption_Homo sapiens_hsa04978 | 1.01519331 |
60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.00734570 |
61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98961212 |
62 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.98208295 |
63 | Influenza A_Homo sapiens_hsa05164 | 0.97872987 |
64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97651577 |
65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.93491907 |
66 | Allograft rejection_Homo sapiens_hsa05330 | 0.93285795 |
67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.92683183 |
68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90331688 |
69 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83884058 |
70 | * Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83419833 |
71 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.79860984 |
72 | Platelet activation_Homo sapiens_hsa04611 | 0.79818729 |
73 | Hepatitis C_Homo sapiens_hsa05160 | 0.79766668 |
74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78489814 |
75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78068854 |
76 | Endocytosis_Homo sapiens_hsa04144 | 0.78051064 |
77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77759305 |
78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76994729 |
79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.76536311 |
80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73687173 |
81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72653495 |
82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.72024752 |
83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70329609 |
84 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70256850 |
85 | Salivary secretion_Homo sapiens_hsa04970 | 0.70249410 |
86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68926896 |
87 | Hepatitis B_Homo sapiens_hsa05161 | 0.68558938 |
88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67764400 |
89 | Peroxisome_Homo sapiens_hsa04146 | 0.67506943 |
90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67452159 |
91 | * Histidine metabolism_Homo sapiens_hsa00340 | 0.61301447 |
92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60648447 |
93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60171721 |
94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58839118 |
95 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57508962 |
96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57394879 |
97 | Prion diseases_Homo sapiens_hsa05020 | 0.54810517 |
98 | Insulin resistance_Homo sapiens_hsa04931 | 0.53218713 |
99 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52346133 |
100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52084631 |
101 | Tight junction_Homo sapiens_hsa04530 | 0.51872247 |
102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51470521 |
103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48457718 |
104 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47562542 |
105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47427398 |
106 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47231479 |
107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47026692 |
108 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.46855950 |
109 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.45587610 |
110 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45331600 |
111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45006308 |
112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44963865 |
113 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43635761 |
114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42945756 |
115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42361265 |
116 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.41781741 |
117 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41473891 |
118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40258058 |
119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.40085437 |
120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40082307 |
121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39564580 |
122 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39140482 |
123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38956554 |
124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38947599 |
125 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.36918130 |
126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36607776 |
127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32555183 |
128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32345008 |
129 | Focal adhesion_Homo sapiens_hsa04510 | 0.31178775 |
130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30537251 |
131 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29110480 |
132 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.27569916 |
133 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26214614 |
134 | Protein export_Homo sapiens_hsa03060 | 0.24667494 |